Table 1.
Gb3 expression and clinicopathological characteristics of primary breast carcinomas
| Feature | Gb3 + | Gb3 - |
|---|---|---|
| Patients | 62 | 45 |
| Age** | 51.0 | 53.9 |
| Lymph node status | ||
| Node-positive | 33 | 34 |
| Node-negative | 29 | 11 |
| Histological type | ||
| Ductal | 58 | 37 |
| Lobular | 1 | 3 |
| Papillary | 2 | 1 |
| Others | 1 | 4 |
| Mitotic index* | 2.0 | 2.5 |
| Grade* | 2.5 | 3.0 |
| Estrogen receptor | ||
| Positive | 48 | 24 |
| Negative | 14 | 21 |
| Progesterone receptor | ||
| Positive | 35 | 20 |
| Negative | 27 | 25 |
| HER2 | ||
| Positive | 40 | 25 |
| Negative | 22 | 20 |
| Molecular classification | ||
| Luminal A | 6 | 7 |
| Luminal B | 42 | 16 |
| Luminal B/HER2 + | 31 | 15 |
| Luminal B/HER2 - | 11 | 1 |
| HER2 positive | 9 | 9 |
| Triple Negative | 5 | 10 |
| Not classified | 0 | 3 |
*Median of mitotic index and grade; **Mean.